“…Blood vessel malformations in the brain, stroke, brain tumors, and several genetic syndromes can also result in TLE. Since a small subset of patients with these known causative factors go on to develop TLE, targeting the “latent-period” 2 with a preventative or disease-modifying therapy would require the ability to accurately predict the most high-risk patients for TLE. However, such predictive biomarkers for TLE have not yet been established.…”